Alan Trounson joins regenerative medicine advisory committee

By Leigh Dayton

7 October 2021

According to Cartherics CEO Alan Trounson, taking ideas from the laboratory to the marketplace is a “long and tortuous process”. First-hand experience goes far towards identifying and navigating the hurdles of research translation.

And experience – from pioneering work in IVF and embryonic stem cell science to leadership at the Californian Institute for Regenerative Medicine and now Cartherics – is what Trounson brings to his new advisory role with the Australian Regenerative Medicine Institute (ARMI).

“I look forward to a collaboration on research, development and commercialisation,” says Trounson. “The association can be beneficial to both parties.”

Trounson’s participation on ARMI’s Industry Advisory Committee follows on from agreements, announced in July, for closer cooperation and collaboration between Cartherics, ARMI and the Centre for the Commercialisation of Regenerative Medicine (CCRM).

https://armi.org.au/about/who-we-are/industry-advisory-committee/

It also fits neatly with the establishment of a new state-of-the-art facility for Cartherics just north of Monash University, ARMI’s home base. “It will herald a new horizon of industry-academic partnerships involving innovation and commercialization in human medicine,” Trounson predicts of the new physical and intellectual association.

ARMI welcomed Trounson in the latest edition of its Regenerate Newsletter.

About ARMI The Australian Regenerative Medicine Institute is one of the largest regenerative medicine and stem cell research organizations globally and Australia’s only research institute specializing in regeneration and stem cells. Located on the Clayton campus of Monash University, researchers at ARMI focus on understanding the basic mechanisms of the regenerative process, aiming to eventually enable doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government.

About CCRM Australia CCRM Australia is an Australian not-for-profit organisation supporting the development of foundational technologies to accelerate the commercialisation of regenerative medicine products and therapies. CCRM Australia’s focus is to bridge the commercialisation gap through a network of scientists, entrepreneurs, academic institutions and industry partners and address bottlenecks in the industry. CCRM Australia is modelled on the highly successful CCRM in Canada and is legally separate from CCRM. As a Global CCRM network member, CCRM Australia is a partner to a leading-edge industry consortium. MTPConnect and the Victorian State Government support CCRM Australia.